Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,760
datasets available to search
ShareScore release 0.9.0
Dataset results
1,760 results for “phase 2”
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated
ClinicalTrials.gov study NCT02512068. IPD Sharing: YES. Countries: 1. Publications: 0.
Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis
ClinicalTrials.gov study NCT05116540. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma
ClinicalTrials.gov study NCT03606174. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment
ClinicalTrials.gov study NCT02047253. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
ClinicalTrials.gov study NCT07267949. IPD Sharing: YES. Countries: 7. Publications: 0.
MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)
ClinicalTrials.gov study NCT00371007. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers.
ClinicalTrials.gov study NCT04086823. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)
ClinicalTrials.gov study NCT03551730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension
ClinicalTrials.gov study NCT02906579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis
ClinicalTrials.gov study NCT05214794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF
ClinicalTrials.gov study NCT03538301. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Phase 2 Study of AT13387 (Onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL
ClinicalTrials.gov study NCT02572453. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
ClinicalTrials.gov study NCT02019693. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease
ClinicalTrials.gov study NCT00403494. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01961882. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
ClinicalTrials.gov study NCT01095653. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer
ClinicalTrials.gov study NCT00633087. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)
ClinicalTrials.gov study NCT03360747. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alvocidib Biomarker-driven Phase 2 AML Study
ClinicalTrials.gov study NCT02520011. IPD Sharing: NO. Countries: 4. Publications: 0.
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
ClinicalTrials.gov study NCT03521479. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.